The use of octreotide to treat congenital chylothorax.
We report the use of the octreotide (a somatostatin analogue) in the treatment of idiopathic congenital chylothorax in a patient with Turner's syndrome who had previously failed conservative medical therapy. The patient improved rapidly after initiation of octreotide with complete resolution after 5 days of continuous therapy (10 microg/kg per hour).
Paget-Brown
Alix
A
Division of Neonatology, Department of Pediatrics, Children's Medical Center, University of Virginia, School of Medicine, P.O. Box 800386, Charlottesville, VA 22901, USA.
Kattwinkel
John
J
Rodgers
Bradley M
BM
Michalsky
Marc P
MP
D002916:Chylothorax / Q000151:congenital* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015282:Octreotide / Q000627:therapeutic use*; D012074:Remission Induction
D015282:Octreotide